ImmunoVaccine Technologies(加拿大)

IVT

加拿大ImmunoVaccineTechnologiesInc.(IVT)www.immunovaccine.comImmunoVaccineTechnologiesInc.(哈立法克斯，Halifax)是發(fā)展疫苗的公司，宣布派任曾任國會議員的MichaelKirby先生接替Dr.WarrickKimmins醫(yī)生，擔(dān)當(dāng)公司新董事長。Dr.WarrickKimmins醫(yī)生在他的任期內(nèi)對公司提供了領(lǐng)導(dǎo) 風(fēng)范，也曾主導(dǎo)DalhousieUniversity大學(xué)上游創(chuàng)新科技移轉(zhuǎn)，成為IVT公司的科技平臺。ImmunoVaccineTechnologiesInc.(IVT)isapre-clinicalstageprivatebiotechnologycompanydevelopingtherapeuticcancerandprophylacticinfectiousdiseasevaccinesforhumanhealth.IVTiscommercializingbreakthroughvaccinesdevelopedthroughthecombinationoftheVacciMax®platform,avaccinedeliveryandenhancementsystemandalargeselectionofvalidatedvaccineantigens.ThecombinationoftherightantigensandstrongnoveldeliverywillgiveIVT’spipelineadistinctcompetitiveadvantageandwillpositionIVTasakeyplayerindevelopmentofpremiumvaccineproducts. TheVacciMax®platformisabletostimulateanearlier,morepowerful,longlastingantib